199 related articles for article (PubMed ID: 28315369)
1. Resveratrol as MDR reversion molecule in breast cancer: An overview.
Alamolhodaei NS; Tsatsakis AM; Ramezani M; Hayes AW; Karimi G
Food Chem Toxicol; 2017 May; 103():223-232. PubMed ID: 28315369
[TBL] [Abstract][Full Text] [Related]
2. Phytoestrogens and breast cancer: In vitro anticancer activities of isoflavones, lignans, coumestans, stilbenes and their analogs and derivatives.
Basu P; Maier C
Biomed Pharmacother; 2018 Nov; 107():1648-1666. PubMed ID: 30257383
[TBL] [Abstract][Full Text] [Related]
3. Resveratrol enhances chemosensitivity of doxorubicin in multidrug-resistant human breast cancer cells via increased cellular influx of doxorubicin.
Kim TH; Shin YJ; Won AJ; Lee BM; Choi WS; Jung JH; Chung HY; Kim HS
Biochim Biophys Acta; 2014 Jan; 1840(1):615-25. PubMed ID: 24161697
[TBL] [Abstract][Full Text] [Related]
4. Assessment of the potential activity of major dietary compounds as selective estrogen receptor modulators in two distinct cell models for proliferation and differentiation.
Lecomte S; Lelong M; Bourgine G; Efstathiou T; Saligaut C; Pakdel F
Toxicol Appl Pharmacol; 2017 Jun; 325():61-70. PubMed ID: 28396216
[TBL] [Abstract][Full Text] [Related]
5. The Role of Resveratrol in Cancer Therapy.
Ko JH; Sethi G; Um JY; Shanmugam MK; Arfuso F; Kumar AP; Bishayee A; Ahn KS
Int J Mol Sci; 2017 Dec; 18(12):. PubMed ID: 29194365
[No Abstract] [Full Text] [Related]
6. Combination Therapy using Co-encapsulated Resveratrol and Paclitaxel in Liposomes for Drug Resistance Reversal in Breast Cancer Cells in vivo.
Meng J; Guo F; Xu H; Liang W; Wang C; Yang XD
Sci Rep; 2016 Mar; 6():22390. PubMed ID: 26947928
[TBL] [Abstract][Full Text] [Related]
7. Effects of diverse dietary phytoestrogens on cell growth, cell cycle and apoptosis in estrogen-receptor-positive breast cancer cells.
Sakamoto T; Horiguchi H; Oguma E; Kayama F
J Nutr Biochem; 2010 Sep; 21(9):856-64. PubMed ID: 19800779
[TBL] [Abstract][Full Text] [Related]
8. Reversal effect of resveratrol on multidrug resistance in KBv200 cell line.
Quan F; Pan C; Ma Q; Zhang S; Yan L
Biomed Pharmacother; 2008 Nov; 62(9):622-9. PubMed ID: 18804944
[TBL] [Abstract][Full Text] [Related]
9. Anti-estrogenic activity of a human resveratrol metabolite.
Ruotolo R; Calani L; Fietta E; Brighenti F; Crozier A; Meda C; Maggi A; Ottonello S; Del Rio D
Nutr Metab Cardiovasc Dis; 2013 Nov; 23(11):1086-92. PubMed ID: 23465317
[TBL] [Abstract][Full Text] [Related]
10. Interaction between doxorubicin and the resistance modifier stilbene on multidrug resistant mouse lymphoma and human breast cancer cells.
Ferreira MJ; Duarte N; Gyémánt N; Radics R; Cherepnev G; Varga A; Molnár J
Anticancer Res; 2006; 26(5A):3541-6. PubMed ID: 17094479
[TBL] [Abstract][Full Text] [Related]
11. The palladacycle, BTC2, exhibits anti-breast cancer and breast cancer stem cell activity.
Kimani S; Chakraborty S; Irene I; de la Mare J; Edkins A; du Toit A; Loos B; Blanckenberg A; Van Niekerk A; Costa-Lotufo LV; ArulJothi KN; Mapolie S; Prince S
Biochem Pharmacol; 2021 Aug; 190():114598. PubMed ID: 33979647
[TBL] [Abstract][Full Text] [Related]
12. Walking a Tightrope: A Perspective of Resveratrol Effects on Breast Cancer.
Bartolacci C; Andreani C; Amici A; Marchini C
Curr Protein Pept Sci; 2018; 19(3):311-322. PubMed ID: 28079008
[TBL] [Abstract][Full Text] [Related]
13. The phytoestrogen genistein enhances multidrug resistance in breast cancer cell lines by translational regulation of ABC transporters.
Rigalli JP; Tocchetti GN; Arana MR; Villanueva SS; Catania VA; Theile D; Ruiz ML; Weiss J
Cancer Lett; 2016 Jun; 376(1):165-72. PubMed ID: 27033456
[TBL] [Abstract][Full Text] [Related]
14. Resveratrol augments paclitaxel treatment in MDA-MB-231 and paclitaxel-resistant MDA-MB-231 breast cancer cells.
Sprouse AA; Herbert BS
Anticancer Res; 2014 Oct; 34(10):5363-74. PubMed ID: 25275030
[TBL] [Abstract][Full Text] [Related]
15. Reversal of multidrug resistance by two nordihydroguaiaretic acid derivatives, M4N and maltose-M3N, and their use in combination with doxorubicin or paclitaxel.
Chang CC; Liang YC; Klutz A; Hsu CI; Lin CF; Mold DE; Chou TC; Lee YC; Huang RC
Cancer Chemother Pharmacol; 2006 Nov; 58(5):640-53. PubMed ID: 16544145
[TBL] [Abstract][Full Text] [Related]
16. Antitumor activity of resveratrol and its sulfated metabolites against human breast cancer cells.
Miksits M; Wlcek K; Svoboda M; Kunert O; Haslinger E; Thalhammer T; Szekeres T; Jäger W
Planta Med; 2009 Sep; 75(11):1227-30. PubMed ID: 19350482
[TBL] [Abstract][Full Text] [Related]
17. Resveratrol attenuates the anticancer efficacy of paclitaxel in human breast cancer cells in vitro and in vivo.
Fukui M; Yamabe N; Zhu BT
Eur J Cancer; 2010 Jul; 46(10):1882-91. PubMed ID: 20223651
[TBL] [Abstract][Full Text] [Related]
18. An AS1411 aptamer-conjugated liposomal system containing a bubble-generating agent for tumor-specific chemotherapy that overcomes multidrug resistance.
Liao ZX; Chuang EY; Lin CC; Ho YC; Lin KJ; Cheng PY; Chen KJ; Wei HJ; Sung HW
J Control Release; 2015 Jun; 208():42-51. PubMed ID: 25637705
[TBL] [Abstract][Full Text] [Related]
19. Collateral sensitivity of resistant MRP1-overexpressing cells to flavonoids and derivatives through GSH efflux.
Lorendeau D; Dury L; Genoux-Bastide E; Lecerf-Schmidt F; Simões-Pires C; Carrupt PA; Terreux R; Magnard S; Di Pietro A; Boumendjel A; Baubichon-Cortay H
Biochem Pharmacol; 2014 Aug; 90(3):235-45. PubMed ID: 24875445
[TBL] [Abstract][Full Text] [Related]
20. Fulvestrant reverses doxorubicin resistance in multidrug-resistant breast cell lines independent of estrogen receptor expression.
Huang Y; Jiang D; Sui M; Wang X; Fan W
Oncol Rep; 2017 Feb; 37(2):705-712. PubMed ID: 28000875
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
